Forbes Magazine dated October 27, 2008 In September Google cofounder Sergey Brin blogged about a distressing bit of news: He carried a genetic marker associated with a higher risk for Parkinson's disease. That intimation of mortality generated sympathy for Brin, of course. It also provided a p.r. boost for 23andMe, the Mountain View, Calif. company that markets the $400 "custom genome scan" that Brin had taken, a company that happens to have been cofounded by his wife, Anne Wojcicki. Brin certainly deserves the sympathy. But 23andMe doesn't deserve the good publicity. The company is marketing an expensive bit of medical technology with little proof that it will do any good. Just 11 months old, 23andMe has already become one of the tech world's cool companies, largely because of the Wojcicki-Brin connection. Rupert Murdoch and...
[read full story]
Your Web Site
